Abstract

The prevalence of obesity and dyslipidemia has increased worldwide. The role of trace elements in the pathogenesis of these conditions is not well understood. This study examines the relationship between dietary zinc (Zn) intake and plasma concentrations of Zn, copper (Cu) and iron (Fe) with lipid profile indicators, fatty acid composition in plasma phospholipids and desaturase enzyme activities in a dyslipidemic population. The role of the newly proposed biomarker of Zn status, the linoleic:dihomo-gama-linolenic acid (LA:DGLA) ratio, in predicting Zn status of dyslipidemic subjects has been explored. The study included 27 dyslipidemic adults, 39–72 years old. Trace elements were determined using atomic absorption spectrometry and fatty acid composition by a liquid gas chromatography. Desaturase activities were calculated from product-precursor fatty acid ratios. Dietary data were obtained using 24 h recall questionnaires. Insufficient dietary intake of Zn, low plasma Zn concentrations and an altered Cu:Zn ratio is related to modified fatty acid profile in subjects with dyslipidemia. Plasma Zn status was associated with obesity. There was no correlation between dietary Zn intake and plasma Zn status. The LA:DGLA ratio was inversely linked to dietary Zn intake. Cu, in addition to Zn, may directly or indirectly, affect the activity of desaturase enzymes.

Highlights

  • The number of people affected by obesity and dyslipidemia has increased significantly during the last two decades, largely attributed to the changes in dietary and lifestyle habits

  • The results offered in the present study add novel information to the limited body of literature on the relationship between the important trace elements (Zn, Cu and Fe) with fat intake and FA

  • We showed that people with dyslipidemia have inadequate dietary intakes of Zn and a low plasma Zn status

Read more

Summary

Introduction

The number of people affected by obesity and dyslipidemia has increased significantly during the last two decades, largely attributed to the changes in dietary and lifestyle habits. Sixty-five percent of the world’s population live in countries where overweight and obesity harm more people than malnutrition [1]. According to the World Health organization (WHO) the worldwide obesity rates have nearly tripled since 1975 [1]. The incidence of obesity related diseases (i.e., hypertension, dyslipidemia, metabolic syndrome) increases [1,2]. Dyslipidemia is described as the presence of non-optimal blood lipids levels. People with dyslipidemia have either increased concentrations of triglycerides or low-density lipoprotein cholesterol (LDL-C), or decreased levels of high-density lipoprotein cholesterol (HDL-C) [3,4]. Raised cholesterol levels cause on average 2.6 million deaths and

Objectives
Methods
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.